International Journal of Pediatric Otorhinolaryngology
Case reportPerinatal airway management of neonatal cervical teratomas
Introduction
Teratomas, etymologically ‘monstrous tumors’, are rare congenital tumors derived from pluripotent cells from all three primordial germ-cell layers. As such, they involve at least one-type of tissue originating from these three embryonic layers, each with varying degrees of differentiation. They also can include non-germ totipotential embryonic cells [1]. They are usually benign; however there have been very rare cases of malignancy or malignant transformation [2], [3], [4]. These can be from areas of germ cell or non-germinal malignant tumor patterns [5].
Teratomas can occur in almost any part of the body [6]. However, they are most commonly located in the sacrococcygeal region, followed by the ovaries, testis, anterior mediastinum, retroperitoneum, and finally the head and neck which account for less than 5% of the total [7]. Cervical teratomas have a nearly 100% mortality due to airway complications if not pro-actively managed, due in part to enlargement of the lesion in the first few days of life [8], [9], [10]. Poor prognostic indicators on pre-natal sonography include: large size (>5 cm), polyhydramnios and hydrops fetalis [6], [9], [11], [12]. Management starts at the time of fetal diagnosis and involves a multi-disciplinary team including: obstetricians, sonologists, pediatric radiologists, neonatologists and pediatric surgery and otolaryngology teams. Ex-utero Intrapartum Treatments (EXIT procedures) are employed in the delivery of fetuses with large head and neck masses to obtain a stable airway while the newborn is maintained on utero-placental circulation [13]. The availability of fetal MRI allows for a more accurate assessment of the airway prior to birth, and therefore more fastidious use of intrapartum treatments.
In light of our recent experience with establishment of a multi-disciplinary fetal airway management team, we performed a retrospective review of newborns with cervical teratomas at our institution.
Section snippets
Methods
After gaining ethical approval from The Royal Children's Hospital Human Research Ethics Committee a retrospective analysis was performed by searching the theatre audit database for keyword “teratoma”. We present the three cases of cervical teratoma that were identified over the preceding twelve-month period.
Case 1
A baby girl from a 22-year-old primigravida mother who was heterozygous for hemochromatosis (carrier phenotype) was found to have a complex cervical mass that was initially detected at the 20-week antenatal ultrasound scan, measuring 45 mm × 30 mm × 34 mm. At 25 weeks the mass measured 52 mm × 43 mm × 45 mm with no evidence of obstructive polyhydramnios. Fetal MRI confirmed a displaced but non-obstructed airway. At 36 weeks the child was delivered via elective cesarean section with neonatal, anesthetic and
Discussion
Our experience with three cases of cervical teratoma underscores the importance of a multi-disciplinary approach to the management of these complex tumors. This encompasses clinical expertise in antenatal imaging, obstetric care, airway management and tumor resection. Close collaboration between radiologists, obstetricians, neonatologists, anesthetists, otolaryngologists, pediatric and plastic surgeons is essential to achieve an optimal outcome for both the mother and child. With careful
Consent
Informed consent was obtained from the patient's guardians before publication of this case series and accompanying images.
Competing interests
The authors declare that they have no competing interests’.
Acknowledgements
The authors would like to acknowledge the work of all the team members involved in the care of these children at the Royal Children's Hospital. Particularly members of the Fetal Medicine Team headed by Associate Professor Ricardo Palma Dias, Neonatal Team headed by Dr. Michael Stewart and Mr. Joe Crameri of the Department of Surgery.
References (19)
The value of AFP in congenital cervical teratoma
J. Pediatr. Surg.
(2003)- et al.
Diagnosis and management of cervical teratomas
Br. J. Oral Maxillofac. Surg.
(2004) Perinatal (fetal and neonatal) germ cell tumors
J. Pediatr. Surg.
(2004)- et al.
Differential diagnosis of sonographically detected tumours in the fetal cervical region
Eur. J. Obstet. Gynecol. Reprod. Biol.
(1985) - et al.
Prenatal diagnosis of vascular anomalies
J. Pediatr. Surg.
(2002) - et al.
Cervical teratomas: an analysis. Literature review and proposed classification
J. Pediatr. Surg.
(1988) Ex-utero intrapartum therapy
Seminal Fetal Neonatal Med.
(2010)- et al.
Spectrum of intrapartum management strategies for giant fetal cervical teratoma
J. Pediatr. Surg.
(2003) - et al.
Short-term maternal outcomes that are associated with the EXIT procedure, as compared with cesarean delivery
Am. J. Obstet. Gynecol.
(2002 Apr)
Cited by (16)
Ex utero intrapartum technique (EXIT): Indications, procedure methods and materno-fetal complications – A literature review
2022, Journal of Gynecology Obstetrics and Human ReproductionCitation Excerpt :In addition, during the postnatal period, cervical teratomas can bleed spontaneously into the upper airways. Intubation to protect the upper airway can therefore be necessary, even in the absence of airway compression [5]. The complete postnatal resection of teratomas is often possible with a good long-term prognosis, even in the presence of metastases [16].
Risk factor analysis and outcomes of airway management in antenatally diagnosed cervical masses
2021, International Journal of Pediatric OtorhinolaryngologyCitation Excerpt :High-grade congenital HN masses, therefore, remain a significant challenge to otorhinolaryngologists, pediatric surgeons, peri- and neonatologists and anesthesia teams tasked with establishing airway control [25]. Furthermore, complex, multidisciplinary management may be required in the postnatal period, as fetal neck masses are associated with significant morbidity and mortality, and documented long-term outcomes are variable [5,7–9,26]. To our knowledge, this study presents the largest single-center retrospective analysis of airway management in patients with antenatally diagnosed cervical masses.
EXIT (ex utero intrapartum treatment) surgery for the management of fetal airway obstruction: A systematic review of the literature
2020, Journal of Pediatric SurgeryCitation Excerpt :We identified 1120 related studies, of which 250 were evaluated in full text to assess the eligibility criteria for their inclusion. Ultimately, 120 studies were included in this review (Fig. 1) [3,5–123]. These articles included 235 cases of EXIT surgery published between 1996 and 2017; 54% (127 cases) were performed in the United States (USA).
Ex utero intrapartum treatment (EXIT) for fetal neck masses: A tertiary center experience and literature review
2019, International Journal of Pediatric OtorhinolaryngologyCitation Excerpt :One hundred ninety one cases were identified from 1981 to 2018. One hundred thirty-seven cases fulfilled our inclusion criteria [3–51]. The majority of these cases were vascular or cystic lesions and one case was a cervical teratoma.
EXIT (ex utero intrapartum treatment) in a growth restricted fetus with tracheal atresia
2018, International Journal of Pediatric OtorhinolaryngologyNeck Teratoma
2018, Obstetric Imaging: Fetal Diagnosis and Care: Second Edition